SHARE PRICE: 1470.00 GBX
Log in Log in Demo Demo
The Craneware Group The Craneware Group
The Craneware Group The Craneware Group
  • Solutions

    Solutions

    Our applications and industry-leading team of experts contextualize operational, financial, and clinical data, providing insights that clearly demonstrate realistic revenue integrity and 340B compliance opportunities for our customers.

    Learn More Learn More
    • Solutions
    • Pricing
      • Pricing
      • Trisus Pricing Transparency
      • Trisus Pricing Analyzer
    • Revenue
      • Revenue
      • Trisus Chargemaster
      • Insight Medical Necessity
      • Trisus Claims Informatics
      • Appeals Services
      • Trisus Supply
      • Trisus Supplies Assistant
      • InSight Audit
      • InSight Denials
    • Cost & Decision Support
      • Cost & Decision Support
      • Trisus Decision Support
      • Trisus Medication Analytic Solutions
      • Trisus Supply
      • Trisus Supplies Assistant
    • 340B & Pharmacy
      • 340B & Pharmacy
      • Sentinel
      • Sentrex
      • Sentrex 330
      • Referral Verification System (Sentrex)
      • Referral Verification System (Senturion)
      • Trisus Medication Analytic Solutions
      • Senturion Professional Service
      • Sentry Core
    • Services
      • Services
      • Professional Services Catalogue
      • Senturion Professional Service
      • Appeals Services
    • Trisus
  • News & Events

    News & Events

    Read the latest news and learn about upcoming training and events with our industry leading experts.

    News & Events News & Events
    • News & Events
    • Press Releases
    • Summit
    • ASHP Midyear
  • Resources

    Resources

    Stay current on thought leadership news and events using with these online resources.

    View Our Publications View Our Publications
    • Resources
    • COVID-19
    • Publications
    • Success Stories
    • Webinars
    • Blogs
  • Company

    Company

    The Craneware Group is recognized as the leading provider of Revenue integrity and 340B management solutions that improve financial performance in the US hospital and health system markets. We’re respected as a healthcare business partner delivering value, quality, and outstanding customer service.

    Our Story Our Story
    • Company
    • Our Story
      • Our Story
      • Values
    • Governance
    • Investors
      • Investors
      • Why Invest
      • Reports
      • Investor Contacts
      • Shareholder Centre
      • AIM Rule 26
      • Advisors
      • AIM securities information
    • Careers
      • Careers
      • Culture
      • Join
    • ESG
    • Leadership
    • Board of Directors
Craneware
Log in Log in Demo Demo
SHARE PRICE: 1470.00 GBX
Craneware

Sitemap

  • Home
  • Sitemap

Solutions

  • Pricing
    • Trisus Pricing Transparency
    • Trisus Pricing Analyzer
  • Revenue
    • Trisus Chargemaster
    • Insight Medical Necessity
    • Trisus Claims Informatics
    • Appeals Services
    • Trisus Supply
    • Trisus Supplies Assistant
    • InSight Audit
    • InSight Denials
  • Cost
    • Trisus Decision Support
    • Trisus Medication Analytic Solutions
    • Trisus Supply
    • Trisus Supplies Assistant
  • 340B & Pharmacy
    • Sentinel
    • Sentrex
    • Sentrex 330
    • Referral Verification System (Sentrex)
    • Referral Verification System (Senturion)
    • Trisus Medication Analytic Solutions (redirect page)
    • Senturion Professional Service (redirect page)
  • Services
    • Professional Services Catalogue
    • Senturion Professional Service
    • Appeals Services
  • Trisus

News & Events

  • Press Releases
  • Summit
  • ASHP Midyear

Resources

  • COVID OLD
    • Pfizer COVID-19 vaccine booster
    • Moderna COVID-19 vaccine booster
    • HCPCS code for the recently authorized higher dosage of EVUSHELD
    • HCPCS codes for the COVID-19 monoclonal antibody treatment bebtelovimab
    • HCPCS code to report when convalescent plasma is administered in the outpatient setting
    • Coding changes related to Pfizer COVID-19 vaccines
    • Remdesivir now approved by the FDA
    • HCPCS code for Remdesivir
    • HCPCS codes for the combined treatment of tixagevimab and cilgavimab
    • Where do I submit bills for Medicare Advantage patients for COVID-19?
    • CPT codes for the Pfizer pediatric COVID-19 vaccine
    • AMA announces new CPT code for booster doses of the Janssen (J&J) COVID-19 vaccine
    • Which CPT codes should I use to report the newly authorized Moderna COVID-19 vaccine booster doses?
    • Is there a new code for administration of the Pfizer vaccine booster dose?
    • CMS announces new HCPCS codes for prophylactic use of casirivimab and imdevimab
    • CMS provides guidance on how to bill for 3rd doses of COVID-19 vaccines
    • AMA announces a new CPT code for a possible 3rd dose of the Pfizer COVID-19 vaccine
    • CMS announces new HCPCS codes to report for the COVID-19 treatment Tocilizumab
    • CMS announces HCPCS code changes for COVID-19 treatments Sotrovimab and REGEN-COV
    • CMS increases the amount it will pay providers for COVID-19 vaccines
  • Publications
  • Success Stories
  • Webinars
  • Blogs

Company

  • Our Story
    • Values
  • Governance
  • Investors
    • Why Invest
    • Reports
    • Investor Contacts
    • Shareholder Centre
    • AIM Rule 26
    • Advisors
    • AIM securities information
  • Careers
    • Culture
    • Join
  • ESG
  • Leadership
  • Board of Directors

Better together. The Craneware Group.

Security Statement

Privacy Policy

Legal

Modern Slavery Statement

Contact

340B coalition

Conversion request

Trisus Chargemaster

Trisus Reference Physician Data

Ready to learn more about Trisus Pricing Transparency?

How can Hospitals Manage the Financial Impact of COVID-19 Pandemic?

The Craneware Group

Solutions

  • Pricing
  • Revenue
  • Cost
  • 340B & Pharmacy
  • Services
  • Trisus

News & Events

  • Press Releases

Resources

  • COVID-19
  • Publications

Company

  • Our Story
  • Governance
  • Investors
  • Careers
  • ESG

Follow us

  • Twitter
  • LinkedIn
© The Craneware Group. All rights reserved.
  • Security Statement
  • Privacy Policy
  • Legal
  • Modern Slavery Statement
  • Contact
  • Sitemap
  • Cookie Settings